339 related articles for article (PubMed ID: 34457187)
1. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors.
Rasic P; Jovanovic-Tucovic M; Jeremic M; Djuricic SM; Vasiljevic ZV; Milickovic M; Savic D
World J Gastrointest Oncol; 2021 Aug; 13(8):799-821. PubMed ID: 34457187
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 role in the immune landscape of cancer.
Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S
Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059
[TBL] [Abstract][Full Text] [Related]
3. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention.
Varghese E; Samuel SM; Brockmueller A; Shakibaei M; Kubatka P; Büsselberg D
Cancer Metastasis Rev; 2024 Mar; 43(1):115-133. PubMed ID: 37768439
[TBL] [Abstract][Full Text] [Related]
4. Targeting B7-H3-A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment.
Rasic P; Jeremic M; Jeremic R; Dusanovic Pjevic M; Rasic M; Djuricic SM; Milickovic M; Vukadin M; Mijovic T; Savic D
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110590
[TBL] [Abstract][Full Text] [Related]
5. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.
Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W
Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer.
Zhang H; Zhu M; Zhao A; Shi T; Xi Q
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189031. PubMed ID: 38036107
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
Zhao B; Li H; Xia Y; Wang Y; Wang Y; Shi Y; Xing H; Qu T; Wang Y; Ma W
J Hematol Oncol; 2022 Oct; 15(1):153. PubMed ID: 36284349
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
Pizon M; Schott DS; Pachmann U; Pachmann K
Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
[TBL] [Abstract][Full Text] [Related]
9. [Research Progress on Co-stimulating Molecule B7-H3 in Hematological Malignancies].
Zhang W; Wang J; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1758-62. PubMed ID: 26708906
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of T cell co-regulator factor B7-H3 with
Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM
Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma.
Zhao J; Meng Z; Xie C; Yang C; Liu Z; Wu S; Wang B; Fan P; Jin X; Wu H
Int J Biochem Cell Biol; 2019 Mar; 108():84-91. PubMed ID: 30664982
[TBL] [Abstract][Full Text] [Related]
12. Expression of CYP1B1 and B7-H3 significantly correlates with poor prognosis in colorectal cancer patients.
Liu X; Wang F; Wu J; Zhang T; Liu F; Mao Y; Hua D
Int J Clin Exp Pathol; 2018; 11(5):2654-2664. PubMed ID: 31938380
[TBL] [Abstract][Full Text] [Related]
13. B7-H3: An Attractive Target for Antibody-based Immunotherapy.
Kontos F; Michelakos T; Kurokawa T; Sadagopan A; Schwab JH; Ferrone CR; Ferrone S
Clin Cancer Res; 2021 Mar; 27(5):1227-1235. PubMed ID: 33051306
[TBL] [Abstract][Full Text] [Related]
14. A promising target for breast cancer: B7-H3.
Jiang Y; Liu J; Chen L; Qian Z; Zhang Y
BMC Cancer; 2024 Feb; 24(1):182. PubMed ID: 38326735
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
Tekle C; Nygren MK; Chen YW; Dybsjord I; Nesland JM; Maelandsmo GM; Fodstad O
Int J Cancer; 2012 May; 130(10):2282-90. PubMed ID: 21671471
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
[No Abstract] [Full Text] [Related]
17. Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon Adenocarcinoma.
Chen LC; Yang PC; Chen CY; Chiang SF; Chen TW; Chen WT; Ke TW; Liang JA; Shiau AC; Chao KSC; Huang KC
J Cancer; 2024; 15(6):1750-1761. PubMed ID: 38370387
[TBL] [Abstract][Full Text] [Related]
18. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
19. Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer.
Li ZY; Wang JT; Chen G; Shan ZG; Wang TT; Shen Y; Chen J; Yan ZB; Peng LS; Mao FY; Teng YS; Liu JS; Zhou YY; Zhao YL; Zhuang Y
Clin Immunol; 2021 Jun; 227():108753. PubMed ID: 33945871
[TBL] [Abstract][Full Text] [Related]
20. B7-H3 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target.
Tan X; Zhao X
Chin Med J (Engl); 2024 Apr; ():. PubMed ID: 38595093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
